$THC

Tenet forecasts 2026 adjusted EBITDA of $5.05B-$5.2B as Conifer transition items lift results (NYSE:THC)

Tenet Healthcare (THC) reported Q3 2026 net operating revenues of $5.6B and adjusted EBITDA of $1.355B. CEO Saumya Sutaria noted an 80% increase in adjusted diluted earnings per share to $6.64. The company forecasts 2026 adjusted EBITDA of $5.05B-$5.2B, driven by Conifer transition items.

Original reporting
Published Oct 29, 2026, 6:49 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 29, 2026, 6:54 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$THC
Bullish
high confidence
Mentioned
$THC
Relevance
8/10
AlphAI data visualization · based on seekingalpha.com
Decision brief

The 30-second read

$THCBullishHigh
01

Why it matters

The disclosed earnings and forward EBITDA guidance provide fresh material for traders to reassess valuation.

02

Market read

The earnings beat and raised 2026 EBITDA outlook are likely to drive short‑term price movement in THC.

03

What to watch

Potential headwinds from regulatory changes or payer reimbursement pressures could temper upside.

Relevance 8/10Novelty 8/10Timing: after‑hours earnings release

Background

Tenet Healthcare (NYSE:THC) released its Q3 2026 earnings via an AI‑generated transcript on Seeking Alpha.

Company-level read

Ticker impact

$THCBullishHigh confidence
Context

Q3 2026 adjusted EBITDA of $1.355 B and net operating revenues of $5.6 B were disclosed in the earnings call.

Expected impact

potential upside as the market prices in the robust earnings and higher 2026 guidance

Evidence & confidence

The earnings beat and forward‑looking EBITDA range are new material information that can move the stock.

Market effects

Strong performance may lift the broader healthcare services sector.

U.S. hospital and outpatient‑care operators could see increased investor interest.

Limited to U.S. healthcare equities; no direct global macro effect.

Counterpoint

If the guidance is already priced in, the stock may face a pull‑back on profit‑taking.

Key entities

  • Tenet Healthcare Corporation

    U.S. healthcare services provider

Related articles

$THCMedAI 9/10

Tenet Healthcare Boosts FY26 Earnings Outlook - Update

Tenet Healthcare (THC) raised its FY26 earnings and adjusted earnings guidance, while narrowing its revenue outlook. The company now expects earnings of $35.82-$37.08 per share, adjusted earnings of $22.05-$23.01 per share, and revenue of $22.05-$22.45 billion. Shares were unchanged at $268.50 in pre-market trading.

$THCHighAI 9/10

Tenet Healthcare (NYSE:THC) exceeds Q3 2026 expectations

Tenet Healthcare (THC) reported Q3 2026 revenue of $5.63B, beating estimates by 2.1% and growing 6.5% YoY. Adjusted EPS of $6.64 surpassed expectations by 42%. The company raised full-year revenue guidance to $22.25B and adjusted EPS guidance to $22.53. Operating and free cash flow margins improved significantly.

$THCMedAI 8/10

Tenet: Q3 Earnings Snapshot

Tenet Healthcare Corp. (THC) reported Q3 earnings of $1B, or $12.41 per share, beating expectations. Revenue was $5.63B, also exceeding forecasts. The company raised its full-year guidance to $22.05-$23.01 per share in earnings and $22.05B-$22.45B in revenue.

$THCHighAI 9/10

Tenet Reports Strong Third Quarter 2026 Results

TENET HEALTHCARE CORP (THC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Tenet Reports Strong Third Quarter 2026 Results; Raises 2026 Financial Outlook • Net income available to common shareholders in third quarter 2026 was $1.000 billion, or $12.41 per diluted share compared to $342 million, or $3.86 in third quarter 2025 • Adjusted dilu